Abstract. NStearoyltyrosine (NsTyr), a synthesized anandamide (AEA) analogue, could exert potent neuroprotective effects on cerebral ischemia models both in vivo and in vitro via intervening in multiple injuries. Glutamate, a major excitatory neurotransmitter, plays a critical role during stroke/cerebral ischemia. In this study, we explored the protective effects of NsTyr on glutamate neurotoxicity in PC12 cells and investigated its underlying mechanisms. NsTyr treatment attenuated glutamateinduced oxidative toxicity in a dosedependent manner and the best perfor mance was observed at 10 mΜ. NsTyr treatment suppressed glutamate-induced upregulation of lipoxygenase 12/15 (LOX 12/15) activity and reactive oxygen species (ROS) elevation, attenuated the increase of BH3interacting domain death agonist (Bid) in the mitochondria, prevented the loss of mitochondria membrane potential and consequently inhibited apoptosisinducing factor (AIF) translocation into the nucleus. The results demonstrated that NsTyr could protect cells against AIFmediated caspaseindependent cell death induced by glutamate, which may be due to the blockage of Bidmediated mitochondrial damage via reducing LOX 12/15 activity and ROS accumulation.